바이오의약품용 서드파티 물류(3PL) 시장 규모, 점유율, 성장 분석 : 공급망별, 서비스 유형별, 지역별 - 업계 예측(2026-2033년)

Global Biopharmaceuticals Third Party Logistics 3pl Market size was valued at USD 132.41 Billion in 2024 and is poised to grow from USD 140.49 Billion in 2025 to USD 225.61 Billion by 2033, growing at a CAGR of 6.1% during the forecast period (2026-2033).

The market for biopharmaceutical third-party logistics (3PL) is experiencing significant growth due to the increasing trend of pharmaceutical companies outsourcing logistics services to handle their distribution networks more efficiently. 3PL providers support pharmaceutical and medical organizations by streamlining the receiving of small molecule pharmaceuticals, fulfilling orders, and managing inventory through advanced warehouse management systems. This not only helps reduce overhead costs and ensures an uninterrupted product supply but also enhances overall organizational efficiency. Factors driving market growth include a heightened focus on optimizing logistics amidst strong sales performances, the rise in biosimilar launches, and the need for innovations in temperature-controlled packaging, particularly following supply chain disruptions experienced during the pandemic. Overall, the biopharmaceutical 3PL market demonstrates a robust outlook.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopharmaceuticals Third Party Logistics 3pl market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopharmaceuticals Third Party Logistics 3pl Market Segments Analysis

Global Biopharmaceuticals Third Party Logistics 3pl Market is segmented by Supply Chain, Service Type and region. Based on Supply Chain, the market is segmented into Cold Chain Logistics and Non-cold Chain Logistics. Based on Service Type, the market is segmented into Transportation, Warehousing and Storage and Other Services. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biopharmaceuticals Third Party Logistics 3pl Market

The increasing need for efficient logistics solutions to safely transport temperature-sensitive medications is anticipated to significantly boost the biopharmaceutical third-party logistics (3PL) market. The expansion of biologics and biosimilars, which necessitate temperature-controlled logistics services for distribution, is a major contributor to this market's growth. Additionally, the rising implementation of automation in manufacturing facilities aims to lower operational costs and is further driving the demand for 3PL services. Moreover, the growing prevalence of chronic illnesses has led to a heightened requirement for biologics, which in turn accelerates the expansion of the biopharmaceutical third-party logistics market.

Restraints in the Global Biopharmaceuticals Third Party Logistics 3pl Market

The global biopharmaceutical third-party logistics (3PL) market faces significant challenges due to the slower development of logistics services in emerging economies compared to those in developed regions. This disparity in service advancement is partly driven by a scarcity of skilled labor within the biopharmaceutical 3PL sector. The lack of qualified professionals hinders the industry's ability to grow and adapt to the increasing demand for logistics services. Consequently, these workforce limitations pose a considerable restraint on the expansion and efficiency of the global pharmaceutical 3PL market, ultimately affecting the overall supply chain and service delivery within the biopharmaceutical industry.

Market Trends of the Global Biopharmaceuticals Third Party Logistics 3pl Market

The Global Biopharmaceuticals Third Party Logistics (3PL) market is witnessing a significant trend towards advanced logistical solutions driven by escalating demand for value-added services. Companies are increasingly investing in research and development to enhance their capabilities, particularly through the integration of smart sensor technology that monitors ambient conditions during transportation. This innovation allows for improved tracking and handling of sensitive biopharmaceutical products, thereby ensuring compliance and safety. Logistics providers like DHL are leveraging these technological advancements to optimize their distribution networks, positioning themselves competitively in a market that emphasizes efficiency, reliability, and regulatory adherence.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Biopharmaceuticals Third Party Logistics 3pl Market Size by Supply Chain & CAGR (2026-2033)

• Market Overview
• Cold Chain Logistics
• Non-cold Chain Logistics

Global Biopharmaceuticals Third Party Logistics 3pl Market Size by Service Type & CAGR (2026-2033)

• Market Overview
• Transportation
  • Air Freight
  • Sea Freight
  • Overland
• Warehousing and Storage
• Other Services

Global Biopharmaceuticals Third Party Logistics 3pl Market Size & CAGR (2026-2033)

• North America (Supply Chain, Service Type)
  • US
  • Canada
• Europe (Supply Chain, Service Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Supply Chain, Service Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Supply Chain, Service Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Supply Chain, Service Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• DHL (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FedEx (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• United Parcel Service (UPS) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuehne+Nagel (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DB Schenker (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agility (Kuwait)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AmerisourceBergen Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cencora, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EVERSANA (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Logistics Network Limited (Hong Kong)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SF Express (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• XPO Logistics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CEVA Logistics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Almac Group (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryoport, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations